A Comparative Study of Carbetocin and Oxytocin in Placental Separation and Postpartum Hemorrhage Control Following Vaginal and Cesarean Deliveries.
Carbetocin may lead to faster placental separation and reduced blood loss compared to oxytocin, but further research is needed to confirm these findings and assess their clinical significance.
Where it sits
this study against the rest of the carbetocin corpusSummary and findings
This study compared the efficacy of carbetocin (100 μg IV) and oxytocin (10 IU IV) in promoting placental separation and controlling postpartum hemorrhage (PPH) in 200 women undergoing vaginal and cesarean deliveries. The results indicated that carbetocin was associated with shorter times for placental separation and reduced blood loss compared to oxytocin. No therapeutic claims are made.
Abstract
Background Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality worldwide. Timely placental separation and effective uterotonic therapy are critical components in the prevention and management of PPH. Oxytocin has been the gold standard for uterotonic use; however, newer agents such as carbetocin offer longer duration of action and may improve maternal outcomes. Comparative evaluation of these agents in both vaginal and cesarean deliveries is essential for optimizing clinical protocols. Aim The aim of this study was to compare the efficacy of carbetocin and oxytocin in promoting placental separation and controlling PPH following normal vaginal delivery (NVD) and lower segment cesarean section (LSCS). Methodology This prospective, comparative observational study was conducted at the Department of Obstetrics and Gynaecology, Dr. D. Y. Patil Medical College, Pune, over a period of 2 years from November 2022 to October 2024. A total of 200 women were enrolled and divided equally into two groups: Group A received 100 μg of intravenous carbetocin, and Group B received 10 IU of intravenous oxytocin. Each group included an equal number of women undergoing NVD and LSCS. Outcomes assessed included time for placental separation, duration of the third stage of labor, estimated blood loss, requirement for additional uterotonics, and incidence of PPH. Results The mean time to placental separation and third-stage duration were significantly shorter in the carbetocin group compared to the oxytocin group. Carbetocin was also associated with reduced intraoperative and postpartum blood loss and a lower need for additional uterotonic agents. The incidence of atonic PPH was notably lower in the carbetocin group, both in vaginal and cesarean deliveries. Conclusion Carbetocin is more effective than oxytocin in achieving faster placental separation, reducing third-stage labor duration, minimizing blood loss, and lowering the risk of atonic PPH in both normal and operative deliveries. Its longer duration of action and reduced need for repeat dosing make it a superior uterotonic agent for PPH prophylaxis.
Background
Postpartum hemorrhage (PPH) is a significant cause of maternal morbidity and mortality, necessitating effective uterotonic therapy for management. Oxytocin has traditionally been the standard treatment; however, carbetocin, with its longer duration of action, may offer advantages. This study aims to compare the efficacy of these two agents in both vaginal and cesarean deliveries, addressing a critical clinical question.
Methods
This was a prospective, comparative observational study conducted over 2 years at Dr. D. Y. Patil Medical College, Pune. A total of 200 women were enrolled and divided into two groups: Group A received 100 μg of intravenous carbetocin, and Group B received 10 IU of intravenous oxytocin. The study assessed outcomes such as time for placental separation, duration of the third stage of labor, estimated blood loss, requirement for additional uterotonics, and incidence of PPH.
Results
The mean time to placental separation and duration of the third stage of labor were significantly shorter in the carbetocin group compared to the oxytocin group. Additionally, carbetocin was associated with reduced intraoperative and postpartum blood loss, and a lower need for additional uterotonics. The incidence of atonic PPH was notably lower in the carbetocin group for both vaginal and cesarean deliveries.
Interpretation
The findings suggest that carbetocin may be more effective than oxytocin in promoting placental separation and controlling blood loss during and after delivery. However, the clinical significance of these findings should be interpreted cautiously, as the effect sizes are not quantified in the abstract. The observational nature of the study, along with the lack of blinding and potential confounding factors, limits the strength of the conclusions.
Key findings
- Mean time to placental separation was significantly shorter in the carbetocin group compared to the oxytocin group.
- Carbetocin group had reduced intraoperative and postpartum blood loss compared to the oxytocin group.
- Lower need for additional uterotonic agents was observed in the carbetocin group.
- Incidence of atonic PPH was lower in the carbetocin group for both vaginal and cesarean deliveries.
Limitations
- Observational study design.
- Sample size of 200 may limit generalizability.
- Follow-up period not specified.
- No blinding reported.